Fresenius SE & Co. KGaA (FSNUF)
USD 34.66
(0.0%)
USD 34.66
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -594 Million EUR | -128.06% |
| 2022 | 2.11 Billion EUR | -24.9% |
| 2021 | 2.81 Billion EUR | -0.14% |
| 2020 | 2.82 Billion EUR | -6.8% |
| 2019 | 3.02 Billion EUR | 49.43% |
| 2018 | 2.02 Billion EUR | 11.74% |
| 2017 | 1.81 Billion EUR | 13.87% |
| 2016 | 1.59 Billion EUR | 17.3% |
| 2015 | 1.35 Billion EUR | 27.27% |
| 2014 | 1.06 Billion EUR | 5.54% |
| 2013 | 1.01 Billion EUR | 9.18% |
| 2012 | 926 Million EUR | -30.27% |
| 2011 | 1.32 Billion EUR | 10.21% |
| 2010 | 1.2 Billion EUR | 21.59% |
| 2009 | 991 Million EUR | 267.04% |
| 2008 | 270 Million EUR | -34.15% |
| 2007 | 410 Million EUR | 24.24% |
| 2006 | 330 Million EUR | 48.65% |
| 2005 | 222 Million EUR | 32.14% |
| 2004 | 168 Million EUR | 46.09% |
| 2003 | 115 Million EUR | -14.18% |
| 2002 | 134 Million EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 278 Million EUR | 145.28% |
| 2024 Q2 | -373 Million EUR | -234.17% |
| 2023 Q3 | -406 Million EUR | -607.5% |
| 2023 Q1 | 463 Million EUR | 14.89% |
| 2023 FY | -594 Million EUR | -128.06% |
| 2023 Q2 | 80 Million EUR | -82.72% |
| 2023 Q4 | -614 Million EUR | -51.23% |
| 2022 Q1 | 599 Million EUR | 20.04% |
| 2022 Q3 | 551 Million EUR | -2.3% |
| 2022 Q4 | 403 Million EUR | -26.86% |
| 2022 FY | 2.11 Billion EUR | -24.9% |
| 2022 Q2 | 564 Million EUR | -5.84% |
| 2021 FY | 2.81 Billion EUR | -0.14% |
| 2021 Q1 | 435 Million EUR | 6.1% |
| 2021 Q2 | 471 Million EUR | 8.28% |
| 2021 Q3 | 413 Million EUR | -12.31% |
| 2021 Q4 | 499 Million EUR | 20.82% |
| 2020 Q4 | 410 Million EUR | -3.98% |
| 2020 Q3 | 427 Million EUR | 3.89% |
| 2020 Q1 | 459 Million EUR | -10.87% |
| 2020 FY | 2.82 Billion EUR | -6.8% |
| 2020 Q2 | 411 Million EUR | -10.46% |
| 2019 Q1 | 453 Million EUR | -12.21% |
| 2019 FY | 3.02 Billion EUR | 49.43% |
| 2019 Q2 | 471 Million EUR | 3.97% |
| 2019 Q3 | 444 Million EUR | -5.73% |
| 2019 Q4 | 515 Million EUR | 15.99% |
| 2018 FY | 2.02 Billion EUR | 11.74% |
| 2018 Q4 | 516 Million EUR | 23.15% |
| 2018 Q3 | 419 Million EUR | -35.74% |
| 2018 Q2 | 652 Million EUR | 48.18% |
| 2018 Q1 | 440 Million EUR | -13.89% |
| 2017 Q4 | 511 Million EUR | 29.04% |
| 2017 FY | 1.81 Billion EUR | 13.87% |
| 2017 Q2 | 450 Million EUR | -1.53% |
| 2017 Q1 | 457 Million EUR | 4.1% |
| 2017 Q3 | 396 Million EUR | -12.0% |
| 2016 Q1 | 362 Million EUR | 0.84% |
| 2016 FY | 1.59 Billion EUR | 17.3% |
| 2016 Q4 | 439 Million EUR | 10.03% |
| 2016 Q3 | 399 Million EUR | 1.53% |
| 2016 Q2 | 393 Million EUR | 8.56% |
| 2015 Q4 | 359 Million EUR | 0.56% |
| 2015 FY | 1.35 Billion EUR | 27.27% |
| 2015 Q2 | 325 Million EUR | 2.52% |
| 2015 Q1 | 317 Million EUR | 23.35% |
| 2015 Q3 | 357 Million EUR | 9.85% |
| 2014 Q2 | 286 Million EUR | 15.32% |
| 2014 Q3 | 276 Million EUR | -3.5% |
| 2014 Q4 | 257 Million EUR | -6.88% |
| 2014 FY | 1.06 Billion EUR | 5.54% |
| 2014 Q1 | 248 Million EUR | -12.68% |
| 2013 Q1 | 219 Million EUR | -9.13% |
| 2013 Q3 | 265 Million EUR | 9.05% |
| 2013 Q4 | 284 Million EUR | 7.17% |
| 2013 FY | 1.01 Billion EUR | 9.18% |
| 2013 Q2 | 243 Million EUR | 10.96% |
| 2012 Q2 | 407 Million EUR | -10.55% |
| 2012 Q1 | 455 Million EUR | 14.32% |
| 2012 FY | 926 Million EUR | -30.27% |
| 2012 Q4 | 241 Million EUR | -0.82% |
| 2012 Q3 | 243 Million EUR | -40.29% |
| 2011 Q4 | 398 Million EUR | 1.27% |
| 2011 Q1 | 263 Million EUR | -24.64% |
| 2011 FY | 1.32 Billion EUR | 10.21% |
| 2011 Q2 | 274 Million EUR | 4.18% |
| 2011 Q3 | 393 Million EUR | 43.43% |
| 2010 Q3 | 346 Million EUR | 15.33% |
| 2010 FY | 1.2 Billion EUR | 21.59% |
| 2010 Q1 | 207 Million EUR | -28.37% |
| 2010 Q4 | 349 Million EUR | 0.87% |
| 2010 Q2 | 300 Million EUR | 44.93% |
| 2009 Q4 | 289 Million EUR | 53.72% |
| 2009 Q3 | 188 Million EUR | -20.0% |
| 2009 Q2 | 235 Million EUR | -15.77% |
| 2009 Q1 | 279 Million EUR | 0.0% |
| 2009 FY | 991 Million EUR | 267.04% |
| 2008 FY | 270 Million EUR | -34.15% |
| 2007 FY | 410 Million EUR | 24.24% |
| 2006 FY | 330 Million EUR | 48.65% |
| 2005 FY | 222 Million EUR | 32.14% |
| 2004 FY | 168 Million EUR | 46.09% |
| 2003 FY | 115 Million EUR | -14.18% |
| 2002 FY | 134 Million EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| The Amacore Group, Inc. | -10.73 Million USD | -5433.29% |
| Arem Pacific Corporation | -53.66 Thousand USD | -1106746.048% |
| Assisted 4 Living, Inc. | -118.27 Thousand USD | -502127.896% |
| BioCorRx Inc. | -3.76 Million USD | -15668.88% |
| Bionik Laboratories Corp. | -4.94 Million USD | -11909.647% |
| Banyan Corp. | -5.48 Million USD | -10733.444% |
| Clearday, Inc. | -14.3 Million USD | -4051.558% |
| Dental Patient Care America, Inc. | 8974.00 USD | 6619221.908% |
| Quantum Medical Transport, Inc. | 222.84 USD | 266559066.074% |
| Empower Clinics Inc. | -2826.87 USD | -21012539.421% |
| First Choice Healthcare Solutions, Inc. | -8.17 Million USD | -7169.406% |
| Selectis Health, Inc. | -3.97 Million USD | -14858.517% |
| Ethema Health Corporation | 1.17 Million USD | 50584.49% |
| HealthLynked Corp. | -1.01 Million USD | -58583.881% |
| HQDA Elderly Life Network Corp. | - USD | Infinity% |
| Healthcare Solutions Management Group, Inc. | -2.78 Million USD | -21204.289% |
| JRSIS Health Care Corporation | -80.91 Thousand USD | -734030.908% |
| Comjoyful International Company | -20.62 Thousand USD | -2879760.37% |
| Medical Facilities Corporation | 18.5 Million USD | 3310.29% |
| MedSmart Group Inc. | -76.23 Thousand USD | -779028.792% |
| North America Frac Sand, Inc. | -798.47 Thousand USD | -74291.623% |
| Nova Leap Health Corp. | -1.05 Million USD | -56220.347% |
| Nexteligent Holdings, Inc. | -295.32 Thousand USD | -201033.662% |
| PAO Group, Inc. | 235.5 Thousand USD | 252320.731% |
| Primemd Inc. | 3.14 Million USD | 19015.872% |
| Raffles Medical Group Ltd | 68.31 Million USD | 969.526% |
| Ryman Healthcare Limited | 2.85 Million USD | 20912.77% |
| Stem Cell Authority, Ltd. | -4233.00 USD | -14032500.992% |
| SETO Holdings, Inc. | - USD | Infinity% |
| Optima Medical Innovations Corp. | -3.96 Million USD | -14895.997% |
| Mycotopia Therapies, Inc. | -1.18 Million USD | -50181.585% |
| U.S. NeuroSurgical Holdings, Inc. | -816 Thousand USD | -72694.118% |
| Veltex Corporation | -1.06 Million USD | -55776.169% |
| World Financial Holding Group | -28.42 Thousand USD | -2089536.249% |
| Xcelerate Inc. | -2.75 Million USD | -21494.503% |